Brief Summary

Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.

Available
Individual Patients
Celiac Disease

Biological: AMG 714

Eligibility Criteria

Inclusion Criteria:

-

Exclusion Criteria:

-

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years
Contacts

Amgen Call Center
866-572-6436
medinfo@amgen.com

NCT Number
Keywords
Refractory Celiac Disease Type II
MeSH Terms
Celiac Disease
Intervention Name
AMG 714